Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02922036 · ClinicalTrials.gov registry record · NA

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

A NA study of Heart Failure, sponsored by EBR Systems.

Active
Registry status
NA
Development phase
300
Enrollment target
20
Study locations

NCT02922036: Active NA study of Heart Failure, sponsored by EBR Systems.

NCT02922036 is a NA study of Heart Failure that is active but no longer recruiting, run by EBR Systems. The registered enrollment target is 300 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02922036, a NA study of Heart Failure, is active but no longer recruiting, sponsored by EBR Systems.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.

Conditions Studied

Heart Failure

Interventions

  • DEVICE WiSE System

Study Locations (20)

Florida

  • Broward Health Medical Center - Fort Lauderdale
  • St. Vincent's Healthcare - Jacksonville
  • Watson Clinic - Lakeland
  • Naples Community Hospital - Naples
  • Northside Hospital and Heart Institute - St. Petersburg

Michigan

  • University of Michigan - Ann Arbor
  • Michigan Heart - Canton
  • Henry Ford Hospital - Detroit
  • William Beaumont Hospital - Hazel Park

Georgia

  • Piedmont Heart Institute - Atlanta
  • Emory Healthcare - Atlanta

Kansas

  • Saint Luke's Health System Kansas City - Kansas City
  • The University of Kansas Medical Center - Kansas City

Alabama

  • Heart Center Research - Huntsville

California

  • University of California, San Diego - La Jolla

Illinois

  • Prairie Heart - Springfield

Indiana

  • St. Vincent's Hospital and Healthcare Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2018-01-17
Est. Completion 2026-06
Phase NA

Sponsor

EBR Systems

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02922036

The ClinicalTrials.gov registry entry for NCT02922036 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The listed sponsor is EBR Systems, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which WiSE System is the first listed.

NCT02922036 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Michigan, Georgia.

Frequently Asked Questions

What is clinical trial NCT02922036 about?

NCT02922036 is a clinical study titled "Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients". This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.

What is the current status of trial NCT02922036?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2018-01-17. Estimated completion is 2026-06.

What conditions does trial NCT02922036 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT02922036?

The interventions under investigation include: WiSE System (DEVICE).

Who is sponsoring clinical trial NCT02922036?

This trial is sponsored by EBR Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02922036 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.